Cerebral blood flow in Alzheimer's disease

Vasc Health Risk Manag. 2012:8:599-611. doi: 10.2147/VHRM.S34874. Epub 2012 Oct 23.

Abstract

Background: Alzheimer's disease (AD) dementia is a consequence of heterogeneous and complex interactions of age-related neurodegeneration and vascular-associated pathologies. Evidence has accumulated that there is increased atherosclerosis/arteriosclerosis of the intracranial arteries in AD and that this may be additive or synergistic with respect to the generation of hypoxia/ischemia and cognitive dysfunction. The effectiveness of pharmacologic therapies and lifestyle modification in reducing cardiovascular disease has prompted a reconsideration of the roles that cardiovascular disease and cerebrovascular function play in the pathogenesis of dementia.

Methods: Using two-dimensional phase-contrast magnetic resonance imaging, we quantified cerebral blood flow within the internal carotid, basilar, and middle cerebral arteries in a group of individuals with mild to moderate AD (n = 8) and compared the results with those from a group of age-matched nondemented control (NDC) subjects (n = 9). Clinical and psychometric testing was performed on all individuals, as well as obtaining their magnetic resonance imaging-based hippocampal volumes.

Results: Our experiments reveal that total cerebral blood flow was 20% lower in the AD group than in the NDC group, and that these values were directly correlated with pulse pressure and cognitive measures. The AD group had a significantly lower pulse pressure (mean AD 48, mean NDC 71; P = 0.0004). A significant group difference was also observed in their hippocampal volumes. Composite z-scores for clinical, psychometric, hippocampal volume, and hemodynamic data differed between the AD and NDC subjects, with values in the former being significantly lower (t = 12.00, df = 1, P = 0.001) than in the latter.

Conclusion: These results indicate an association between brain hypoperfusion and the dementia of AD. Cardiovascular disease combined with brain hypoperfusion may participate in the pathogenesis/pathophysiology of neurodegenerative diseases. Future longitudinal and larger-scale confirmatory investigations measuring multidomain parameters are warranted.

Keywords: Alzheimer’s disease; arteriosclerosis; atherosclerosis; brain hypoperfusion; brain morphometric analyses; cerebral blood flow; cognitive impairment; two-dimensional phase-contrast magnetic resonance imaging.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology*
  • Alzheimer Disease / psychology
  • Apolipoprotein E4 / metabolism
  • Blood Pressure / physiology
  • Case-Control Studies
  • Cerebral Arteries / physiopathology*
  • Cerebrovascular Circulation / physiology
  • Cognition / physiology
  • Cohort Studies
  • Female
  • Hippocampus / pathology
  • Humans
  • Magnetic Resonance Angiography / methods
  • Magnetic Resonance Imaging
  • Male
  • Pilot Projects
  • Psychometrics

Substances

  • Apolipoprotein E4